Images List Premium Download Classic

Cellular

Cellular-related patent applications - as published by the U.S. Patent and Trademark Office (USPTO).


loading
Ip based cellular communication system utilizing advanced tunnels and encapsulation methods useful in conjunction therewith
Elta Systems Ltd.
October 12, 2017 - N°20170295535

A dynamic hierarchical cellular system implementing multi-hop encapsulation, wherein in at least one message destined for an individual base station functionality, the individual base station functionality's header is encapsulated within an individual mobile station functionality's header, so as to allow said message to be routed by said router to the individual base station functionality, via the individual mobile station functionality.
Communication apparatus
Elta Systems Ltd.
October 12, 2017 - N°20170295522

A communication system that allows for automatic switching between cellular and a wireless local area network is disclosed.
Dynamic selection and monitoring of wireless communication interfaces for cellular wireless access data offload in ...
Sooktha Consulting Private Limited
October 12, 2017 - N°20170295512

A method and a wireless access interface selection and monitoring system (waisms) for dynamically selecting and monitoring wireless communication interfaces (wcis) associated with wireless access points (waps) in a wireless access network for offloading data from a cellular wireless communication (cwc) interface in a cwc network to the selected wcis are provided. The waisms generates and dynamically updates network latency ...
Cellular Patent Pack
Download 465+ patent application PDFs
Cellular Patent Applications
Download 465+ Cellular-related PDFs
For professional research & prior art discovery
inventor
  • 465+ full patent PDF documents of Cellular-related inventions.
  • Exact USPTO filing data with full-text, images, drawings & claims.
  • Index pages: Table View and Image-Grid View layouts. All images in each PDF.
Optimization of cellular network architecture based on device type-specific traffic dynamics
Board Of Trustees Of Michigan State University
October 12, 2017 - N°20170295501

A method, a computer readable medium and an apparatus for optimizing a cellular network architecture are disclosed. For example, the method obtains network traffic data for a plurality of different endpoint device types, wherein the network traffic data comprises network traffic data for each of the plurality of different endpoint device types, and predicts a future traffic pattern for one ...
Method for scheduling unlicensed spectrum, user equipment, and base station
Huawei Technologies Co., Ltd.
October 12, 2017 - N°20170295499

Embodiments of the present invention provide a method which includes: first, receiving, by user equipment ue, a first scheduling time sent by a base station, where the first scheduling time is a time used by the ue to use the unlicensed spectrum based on a wireless cellular network and/or a time used by the ue to use the unlicensed ...
Method and apparatus for u-plane sub-service flow mapping
Nokia Technologies Oy
October 12, 2017 - N°20170295105

A method, apparatus and computer program product are provided for sub-service flow based mapping in a cellular communication system. A sub-service flow user-plane interface between an enforcement point and a network control system (ncs) is defined. Relation and coordination of the sub-service flow user-plane interface associated with sub-service flow management actions on a control-plane interface is defined. In-band packet marking ...
Cellular Patent Pack
Download 465+ patent application PDFs
Cellular Patent Applications
Download 465+ Cellular-related PDFs
For professional research & prior art discovery
inventor
  • 465+ full patent PDF documents of Cellular-related inventions.
  • Exact USPTO filing data with full-text, images, drawings & claims.
  • Index pages: Table View and Image-Grid View layouts. All images in each PDF.
Adjustable mounting clip and system using same
Daymen Us, Inc.
October 12, 2017 - N°20170293208

An adjustable mounting clip for an electronic device, such as a cellular telephone or smart phone. The mounting clip may be adapted to be supported by a flexible support apparatus, such as a tripod. The mounting clip may support a variety of electronic device types with an automatically adjusting variable device receiver. The mounting clip may be adapted to retract ...
Magnifying device for a mobile device
Daymen Us, Inc.
October 12, 2017 - N°20170293150

A magnifying device for a mobile device is a case, for inserting a cellular phone into, that has a see-through front cover with a magnifying screen for enlarging the print on the screen of the cellular phone. A pocket on the back cover holds a thin magnifier for using to enlarge the minute print often used in cellular phone menus.
Systems and methods for assessing inter-cell communication
Q-state Biosciences, Inc.
October 12, 2017 - N°20170292961

The invention relates to methods of assessing communication between cells. Methods of the invention use optical reporters of cellular electrical activity to evaluate signal propagation between cells and can be used to study an individual synapse or a complex network of interconnected cells. Aspects of the invention provide a method for characterizing signal propagation between cells. The method includes providing ...
Hla g-modified cells and methods
Escape Therapeutics, Inc.
October 12, 2017 - N°20170292952

Disclosed herein are methods for producing genetically modified cells expressing hla-g (e. G., cell surface hla-g) persistently, and nucleic acid compositions useful for generating such genetically modified cells. Also disclosed are cell therapy methods that utilize genetically modified cells that express hla-g persistently. The hla-g genetic modifications described herein provide the cells with characteristics of reduced immunogenicity and/or improved ...
Methods of stratifying patients for treatment with retinoic acid receptor-alpha agonists
Syros Pharmaceuticals, Inc.
October 12, 2017 - N°20170292165

Described herein are methods that define cellular populations that are sensitive to rara agonists and identify patient populations that will benefit from treatment with rara agonists. The methods may comprise administering rara agonists to patient populations.
Phenotypic engineering of spores
Bcr Diagnostics, Inc.
October 12, 2017 - N°20170292143

The biological functionality of living microbial spores is modified using phenotypic engineering to endow the resulting modified spores with novel functionality that extends the usefulness of the spores for a variety of practical applications including, for example, sterility testing, the release of active compounds, and cell-based biosensing systems. An embodiment entails engineering bacillus spores to acquire synthetic new functions that ...
Inflammation-targeted neutrophil granulocyte drug delivery system and use thereof
China Pharmaceutical University
October 12, 2017 - N°20170292113

Disclosed are an inflammation-targeted neutrophil granulocyte drug delivery system and use thereof, wherein the drug delivery system includes neutrophil granulocytes and a therapeutic substance or a detectable substance loaded into the neutrophil granulocytes or onto the surface of the neutrophil granulocytes in a direct or indirect way. By using the neutrophil granulocytes as a carrier of a drug, the drug ...
Cellular Patent Pack
Download 465+ patent application PDFs
Cellular Patent Applications
Download 465+ Cellular-related PDFs
For professional research & prior art discovery
inventor
  • 465+ full patent PDF documents of Cellular-related inventions.
  • Exact USPTO filing data with full-text, images, drawings & claims.
  • Index pages: Table View and Image-Grid View layouts. All images in each PDF.
Bispecific her2 antibodies
Medlmmune, Llc
October 12, 2017 - N°20170291955

The present invention relates to anti-her2 binding molecules (e. G., antibodies and antigen binding fragments thereof), derived her2-binding molecules (e. G., bispecific anti-her2 antibodies), and antibody-drug conjugates (adc) that bind the extracellular domain of the her2 receptor. Also provided are pharmaceutical formulation comprising the disclosed compositions and method for the treating diseases associated with her2-mediated signal transduction.
Targeting aneurysm disease by modulating phagocytosis pathways
The Board Of Trustees Of The Leland Stanford Junior University
October 12, 2017 - N°20170291945

In the methods of the invention, an agent that increases phagocytosis and/or efferocytosis of cellular components of coronary plaque is administered to the subject in a dose and for a period of time effective to stabilize, prevent or reduce aneurysm disease in the individual.
Bmprii polypeptides and uses thereof
Acceleron Pharma, Inc.
October 12, 2017 - N°20170291933

In certain aspects, the present disclosure relates to the insight that a polypeptide comprising a ligand-binding portion of the extracellular domain of bone morphogenetic protein receptor type ii (bmprii) polypeptide binds to ligands including bmp10, bmp15, activin b and bmp9 and may be used to treat fibrotic and angiogenic disorders.
Means and methods for active cellular immunotherapy of cancer by using tumor cells killed by ...
Sotio A.s.
October 12, 2017 - N°20170290899

Disclosed are pharmaceutical compositions for inducing an immune response against tumor cells comprising tumor cells which are made apoptotic by treatment with high hydrostatic pressure and dendritic cells, and methods for producing such compositions.
Treatment of infection by human enterovirus d68
Ansun Biopharma, Inc.
October 12, 2017 - N°20170290893

The present disclosure provides compositions and methods for treating an infection by ev-d68. In particular, the present disclosure provides methods that entail administering agents having an anchoring domain that anchors the compound to the surface of a target cell, and a sialidase domain that can act extracellularly to inhibit infection of a target cell by ev-d68.
Nicotinamide mononucleotide derivatives and their uses
Metro International Biotech, Llc
October 12, 2017 - N°20170290850

The invention relates to compositions of nicotinamide mononucleotide derivatives and their methods of use. The invention also relates to methods of preparing nicotinamide mononucleotide derivatives. The invention relates to pharmaceutical compositions and nutritional supplements containing a nicotinamide mononucleotide derivative. The invention relates to methods of using nicotinamide mononucleotide derivatives that promote the increase of intracellular levels of nicotinamide adenine dinucleotide (...
Quinazolines and azaquinazolines as dual inhibitors of ras/raf/mek/erk and pi3k/akt/...
Asana Biosciences, Llc
October 12, 2017 - N°20170290838

The present application provides novel quinazolines and azaquinazolines and pharmaceutically acceptable salts thereof. Also provided are methods for preparing these compounds. These compounds are useful in for co-regulating ras/raf/mek/erk and pi3k/akt/pten/mtor pathways by administering a therapeutically effective amount of one or more of the compounds of formula (i), wherein x, y, t and ...
Necrosis inhibitors
National Institute Of Biological Sciences, Beijing
October 12, 2017 - N°20170290790

The invention provides amides that inhibit cellular necrosis and/or human receptor interacting protein 1 kinase (rip1), including corresponding sulfonamides, and pharmaceutically acceptable salts, hydrides and stereoisomers thereof. The compounds are employed in pharmaceutical compositions, and methods of making and use, including treating a person in need thereof with an effective amount of the compound or composition, and detecting a resultant ...
Loading